Advertisement
Screener

CORCEPT THERAPEUTICS INC (CORT) Graph

CORT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $256.15M; Cost of revenue $4.06M; Research and development $53.89M; Selling, general and administrative $156.90M.
  • 2026-03-31: Revenue $164.90M; Cost of revenue $2.88M; Research and development $66.27M; Selling, general and administrative $145.36M.
  • 2025-12-31: Revenue $202.13M*; Cost of revenue $2.54M*; Research and development $64.86M*; Selling, general and administrative $130.24M*.
  • 2025-09-30: Revenue $207.64M; Cost of revenue $4.60M; Research and development $68.85M; Selling, general and administrative $123.98M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CORT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.HypercortisolismProducts$208.58MLifyorli$47.56MRevenue$256.15MCost of revenue$4.06MOperating income$41.30MResearch & development$53.89MSelling, general& administrative$156.90MPre-tax income$45.93MNet income$42.99M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$256.15M$4.06M$53.89M$156.90M(m)$2.94M$42.99M
2026-03-31$164.90M$2.88M$66.27M$145.36M(m)-$12.95M-$31.76M
2025-12-31$202.13M*$2.54M*$64.86M*$130.24M*(m)-$14.38M*$24.29M*
2025-09-30$207.64M$4.60M$68.85M$123.98M(m)-$4.42M$19.67M
2025-06-30$194.43M$3.43M$60.47M$103.85M(m)-$3.46M$35.15M
2025-03-31$157.21M$2.40M$60.73M$90.66M(m)-$10.93M$20.55M
2024-09-30$182.55M$2.87M$59.34M$73.75M(m)$5.73M$47.21M
2024-06-30$163.80M$2.52M$58.74M$66.94M(m)$6.11M$35.49M
2024-03-31$146.81M$2.54M$58.51M$56.27M(m)$7.23M$27.76M
2023-09-30$123.60M$1.65M$45.52M$45.26M(m)$5.01M$31.38M
2023-06-30$117.72M$1.57M$43.28M$43.28M(m)$5.40M$27.53M
2023-03-31$105.65M$1.39M$40.85M$48.56M(m)$2.56M$15.88M
2022-09-30$101.73M$1.34M$33.29M$35.16M(m)-$1.60M$34.61M
2022-06-30$103.39M$1.32M$32.83M$37.81M(m)$4.65M$27.41M
2022-03-31$93.69M$1.25M$28.12M$37.55M(m)$4.05M$22.80M
2021-09-30$96.13M$1.27M$28.09M$30.53M(m)$5.83M$30.47M
2021-06-30$91.59M$1.38M$28.23M$30.03M(m)$5.53M$26.52M
2021-03-31$79.44M$1.27M$29.02M$29.51M(m)-$3.55M$23.46M
2020-12-31$85.73M(m)(m)(m)(m)(m)$25.99M
2020-09-30$86.33M$1.22M$33.87M$26.52M(m)$3.72M$21.63M
2020-06-30$88.56M$1.23M$26.50M$25.57M(m)$7.95M$28.33M
2020-03-31$93.25M$1.88M$26.12M$27.54M(m)$9.12M$30.07M
2019-12-31$87.89M(m)(m)(m)(m)(m)$29.38M
2019-09-30$81.50M$1.45M$22.80M$24.25M(m)$8.01M$26.34M
2019-06-30$72.26M$1.38M$21.66M$24.59M(m)$5.63M$20.19M
2019-03-31$64.83M$1.24M$20.24M$24.39M(m)$1.78M$18.27M
2018-12-31$66.83M(m)(m)(m)(m)(m)$22.01M
2018-09-30$64.44M$1.31M$18.86M$21.31M(m)$5.98M$17.75M
2018-06-30$62.31M$1.15M$20.54M$19.98M(m)$3.00M$18.20M
2018-03-31$57.66M$1.17M$17.05M$18.44M(m)$3.83M$17.46M
2017-12-31$53.28M(m)(m)(m)(m)(m)$98.33M
2017-09-30$42.76M$976.00K$11.69M$16.47M(m)-$48.00K$13.76M
2017-06-30$35.56M$775.00K$7.88M$14.11M(m)$50.00K$12.65M
2017-03-31$27.60M(m)$7.18M$15.04M(m)$127.00K$4.39M
2016-12-31(m)(m)(m)(m)(m)(m)$4.60M
2016-09-30(m)(m)$7.05M$10.93M(m)$0.00$2.58M
2016-06-30(m)(m)$5.67M$12.12M(m)$0.00$977.00K
2016-03-31(m)(m)$4.63M$10.43M(m)$0.00-$19.00K
2015-12-31(m)$364.00K*(m)(m)(m)(m)$959.00K
2015-09-30(m)$256.00K$3.61M$9.29M$13.16M(m)-$601.00K
2015-06-30(m)$439.00K$3.34M$9.34M$13.12M(m)-$1.94M
2015-03-31(m)$302.00K$4.38M$9.45M$14.13M(m)-$4.83M
2014-12-31(m)(m)(m)(m)(m)(m)-$3.90M
2014-09-30(m)$235.00K$3.05M$9.10M$12.38M(m)-$6.01M
2014-06-30(m)$215.00K$4.25M$7.96M$12.43M(m)-$7.55M
2014-03-31(m)$174.00K$7.29M$9.80M$17.26M(m)-$13.93M
2013-12-31(m)(m)(m)(m)(m)(m)-$11.12M
2013-09-30(m)$40.00K$5.16M$7.18M$12.37M(m)-$10.91M
2013-06-30(m)$23.00K$4.49M$8.16M$12.67M(m)-$11.90M
2013-03-31(m)$20.00K$4.26M$8.38M$12.66M(m)-$12.08M
2012-12-31(m)(m)(m)(m)(m)(m)-$11.12M
2012-09-30(m)$24.00K$3.01M$5.69M$8.73M(m)-$8.29M
2012-06-30(m)$48.00K$2.67M$5.75M$8.47M(m)-$7.60M
2012-03-31(m)(m)$3.54M$7.49M$11.03M(m)-$11.03M
2011-12-31(m)(m)(m)(m)(m)(m)-$9.94M
2011-09-30(m)(m)$3.23M$3.21M$6.44M(m)-$6.43M
2011-06-30(m)(m)$6.20M$2.67M$8.87M(m)-$8.88M
2011-03-31(m)(m)$4.92M$2.17M$7.10M(m)-$7.10M
2010-09-30(m)(m)$5.22M(m)$7.11M(m)-$7.10M
2010-06-30(m)(m)$4.57M(m)$6.45M(m)-$5.70M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$421.05M$6.94M$120.16M$302.25M(m)-$10.01M$11.23M
2025-06-30$351.64M$5.84M$121.21M$194.51M(m)-$14.39M$55.70M
2024-06-30$310.60M$5.06M$117.25M$123.20M(m)$13.34M$63.25M
2023-06-30$223.37M$2.96M$84.13M$91.84M(m)$7.96M$43.41M
2022-06-30$197.07M$2.57M$60.95M$75.36M(m)$8.70M$50.21M
2021-06-30$171.03M$2.65M$57.25M$59.54M(m)$1.98M$49.99M
2020-06-30$181.81M$3.11M$52.62M$53.11M(m)$17.06M$58.39M
2019-06-30$137.09M$2.62M$41.90M$48.98M(m)$7.40M$38.46M
2018-06-30$119.97M$2.33M$37.59M$38.42M(m)$6.83M$35.66M
2017-06-30$63.16M$1.42M$15.05M$29.15M(m)$177.00K$17.04M
2016-06-30(m)(m)$10.31M$22.55M(m)$0.00$958.00K
2015-06-30(m)$741.00K$7.72M$18.80M$27.25M(m)-$6.77M
2014-06-30(m)$389.00K$11.54M$17.77M$29.70M(m)-$21.48M
2013-06-30(m)$43.00K$8.75M$16.54M$25.34M(m)-$23.98M
2012-06-30(m)$48.00K$6.21M$13.24M$19.50M(m)-$18.63M
2011-06-30(m)(m)$11.13M$4.84M$15.97M(m)-$15.98M
2010-06-30(m)(m)$9.06M(m)$12.51M(m)-$11.77M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$559.28M$10.43M$190.05M$318.49M(m)-$18.81M$75.36M
2024-09-30$493.15M$7.93M$176.59M$196.95M(m)$19.07M$110.46M
2023-09-30$346.97M$4.60M$129.65M$137.11M(m)$12.96M$74.78M
2022-09-30$298.80M$3.90M$94.24M$110.53M(m)$7.10M$84.82M
2021-09-30$267.16M$3.93M$85.34M$90.07M(m)$7.81M$80.46M
2020-09-30$268.14M$4.33M$86.49M$79.63M(m)$20.78M$80.02M
2019-09-30$218.59M$4.07M$64.70M$73.23M(m)$15.42M$64.80M
2018-09-30$184.42M$3.64M$56.45M$59.73M(m)$12.81M$53.40M
2017-09-30$105.92M$2.40M$26.75M$45.62M(m)$129.00K$30.79M
2016-09-30(m)(m)$17.36M$33.48M(m)$0.00$3.54M
2015-09-30(m)$997.00K$11.33M$28.09M$40.41M(m)-$7.37M
2014-09-30(m)$624.00K$14.58M$26.87M$42.08M(m)-$27.49M
2013-09-30(m)$82.00K$13.90M$23.72M$37.71M(m)-$34.89M
2012-09-30(m)$72.00K$9.22M$18.93M$28.22M(m)-$26.92M
2011-09-30(m)(m)$14.36M$8.05M$22.40M(m)-$22.42M
2010-09-30(m)(m)$14.29M(m)$19.61M(m)-$18.87M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$761.41M$12.98M$254.91M$448.73M(m)-$33.19M$99.65M
2024-12-31$675.04M$10.88M$246.89M$280.32M(m)$20.28M$141.21M
2023-12-31$482.38M$6.48M$184.35M$184.26M(m)$18.42M$106.14M
2022-12-31$401.86M$5.38M$130.99M$152.85M(m)$14.77M$101.42M
2021-12-31$365.98M$5.28M$113.86M$122.36M(m)$12.49M$112.51M
2020-12-31$353.87M$5.58M$114.76M$105.33M(m)$25.59M$106.01M
2019-12-31$306.49M$5.50M$89.02M$100.36M(m)$22.50M$94.18M
2018-12-31$251.25M$5.21M$75.25M$81.29M(m)$16.74M$75.41M
2017-12-31$159.20M$3.55M$40.38M$62.42M(m)-$76.32M$129.12M
2016-12-31$81.32M$2.06M$23.84M$45.24M(m)$0.00$8.14M
2015-12-31(m)$1.36M$15.42M$36.95M(m)$0.00-$6.41M
2014-12-31(m)$882.00K$18.37M$34.92M$54.17M$0.00-$31.38M
2013-12-31(m)$143.00K$20.47M$31.24M$51.85M(m)-$46.01M
2012-12-31(m)$91.00K$14.07M$25.41M$39.58M(m)-$38.05M
2011-12-31(m)(m)$21.00M$11.33M$32.33M(m)-$32.35M
2010-12-31(m)(m)$18.95M$8.49M$27.44M(m)-$25.97M
2009-12-31$29.00K(m)$14.40M(m)$20.28M(m)-$20.17M
2008-12-31(m)(m)(m)(m)(m)(m)-$20.06M
2007-12-31(m)(m)(m)(m)(m)(m)-$11.57M
2006-12-31(m)(m)(m)(m)(m)(m)-$24.87M
2005-12-31(m)(m)(m)(m)(m)(m)-$20.09M
2004-12-31(m)(m)(m)(m)(m)(m)-$15.54M
2003-12-31(m)(m)(m)(m)(m)(m)-$9.81M
2002-12-31(m)(m)(m)(m)(m)(m)-$18.50M
2001-12-31(m)(m)(m)(m)(m)(m)-$7.45M
2000-12-31(m)(m)(m)(m)(m)(m)-$1.85M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52